The IMPACT Initiative Learning Center: Lower Limb/Leg and Calf Region
Released On
November 15, 2022
Expires On
December 31, 2024
Media Type
Internet
Completion Time
30 minutes
Specialty
Neurology, Other, Physiatry, Primary Care
Topic(s)
Parkinson's & Movement Disorders, Rehabilitation
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.
This activity is supported by an educational grant from Allergan (now AbbVie).
Credit Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews use of ultrasound guidance for optimizing botulinum neurotoxin injections in the leg and calf region including pattern recognition, scanning tips, and needle guidance techniques
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss ultrasound scanning techniques for identification of muscles, nerves, and bones in the lower limb (calf, leg) region
- Identify key muscles, nerves, and bones in the lower limb (leg, calf) using ultrasound pattern recognition
Faculty
Katharine E. Alter, MD
Pediatric/Adult Physiatrist
Mount Washington Pediatric Hospital
Clinical Assistant Professor, Pediatrics, Physical Medicine Rehabilitation
AT Still University
Mesa, Arizona
David M. Simpson, MD, FAAN
Professor of Neurology
Icahn School of Medicine
Director, Neuromuscular Disease Division
Director, Clinical Neurophysiology Laboratories
Director, Neuro-AIDS Program
Mount Sinai
New York, NY
Credit Designation
Credit provided by AKH Inc., Advancing Knowledge in Healthcare
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.
Disclosures of Conflicts of Interest
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Katharine E. Alter, MD has disclosed no financial relationships.
- David M. Simpson MD,FAAN
-
- Consultant: Merz, Allergan/Abbvie, Ipsen
- Researcher: Allergan, Merz, Ipsen
Staff/Reviewers
Dorothy Caputo, MA, BSN, RN, AKH CE Director of Accreditations, has disclosed no financial relationships.
Michele Bielarski, RN, Nurse Reviewer, has disclosed no financial relationships.
Trish Brignoni, AKH Director of Operations, has disclosed no financial relationships.
AKH and Catalyst Medical Education, LLC Planners and Reviewers, have disclosed no financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
Instructions for Participation and Credit
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Contact Information
If you have questions about this activity, please contact AKH Inc. at [email protected].